US2021017239A1PendingUtilityA1
Proteins with diagnostic and therapeutic uses
Assignee: UNIV COURT UNIV OF EDINBURGHPriority: Oct 14, 2013Filed: Aug 17, 2020Published: Jan 21, 2021
Est. expiryOct 14, 2033(~7.2 yrs left)· nominal 20-yr term from priority
A61P 7/00A61P 13/12A61K 38/00C07K 14/472A61L 27/54G01N 2333/3156C07K 14/3156A61P 25/28A61P 27/02A61P 17/00A61L 27/34A61K 38/164A61K 9/48G01N 2333/4716A61L 31/10A61L 31/16A61P 13/02A61L 29/085A61L 29/16
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A recombinant protein for use in the treatment of one or more medical complications associated with aberrant complement regulatory activity in a subject, the recombinant protein capable of binding to complement factor H (CFH) and inducing increased binding of C3d and C3b by bound CFH compared to unbound CFH.
Claims
exact text as granted — not AI-modified1 . A recombinant protein for use in the treatment of one or more medical complications associated with aberrant complement regulatory activity in a subject, the recombinant protein capable of binding to complement factor H (CFH) and inducing increased binding of C3d and C3b by bound CFH compared to unbound CFH.
2 . The recombinant protein of claim 1 , wherein the protein is capable of binding to wild type CFH to form a complex with a K D of 1×10 −10 M or lower.
3 . The recombinant protein of claim 1 , wherein the protein is derived from a bacterial virulence factor.
4 . The recombinant protein of claim 2 , wherein the protein is derived from a bacterial virulence factor.
5 . The recombinant protein of claim 1 , wherein the protein is derived from a pneumococcal surface protein.
6 . The recombinant protein of claim 5 , wherein the protein is derived from pneumococcal surface protein C (PspC) from Streptococcus pneumoniae.
7 . The recombinant protein of claim 5 , wherein the protein is derived from PspC of strain D39 (NCTC no 7466) of S. pneumoniae or PspC of strain TIGR4 (NCTC no 7465) of S. pneumoniae.
8 . The recombinant protein of claim 5 , wherein the protein comprises a fragment of PspC, or a variant thereof, which is from 70 to 150 amino acids in length.
9 . The recombinant protein of claim 2 , wherein the protein is derived from a pneumococcal surface protein.
10 . The recombinant protein of claim 9 , wherein the protein is derived from pneumococcal surface protein C (PspC) from Streptococcus pneumoniae.
11 . The recombinant protein of claim 9 , wherein the protein is derived from PspC of strain D39 (NCTC no 7466) of S. pneumoniae or PspC of strain TIGR4 (NCTC no 7465) of S. pneumoniae.
12 . The recombinant protein of claim 9 , wherein the protein comprises a fragment of PspC, or a variant thereof, which is from 70 to 150 amino acids in length.
13 . The recombinant protein of claim 1 , wherein the protein comprises the sequence:
(SEQ ID NO 1)
ATENEGSTQAATSSNMAKTEHRKAAKQVVDEYIEKMLREIQLDRRK
HTQNVALNIKLSAIKTKYLRELNVLEEKSKDELPSEIKAKLDAAFE
KFKKDTLKPGEK,
or a functional variant or fragment thereof; or
KQVVDEYIEKMLREIQLDRRKHTQNVALNIKLSAIKTKYLRELNVLEEKSKDELPSEIKAKLDAAFEKFKKDTLKPGEK (SEQ ID NO 2), or a functional variant or fragment thereof; or
ATENEGATQVPTSSNRANESQAEQGEQPKKLDSERDKARKEVEEYVKKIVGESYAKSTKKRHTITVALVNELNNIKNEYLNKIVESTSESQLQILMMESRSKVDEAVSKFEKDSSSSSSSDSSTKPEASDTAKPNKPTEPGEK (SEQ ID NO 9), or a functional variant or fragment thereof.
14 . The recombinant protein of claim 2 , wherein the protein comprises the sequence:
(SEQ ID NO 1)
ATENEGSTQAATSSNMAKTEHRKAAKQVVDEYIEKMLREIQLDRRK
HTQNVALNIKLSAIKTKYLRELNVLEEKSKDELPSEIKAKLDAAFE
KFKKDTLKPGEK,
or a functional variant or fragment thereof; or
KQWDEYIEKMLREIQLDRRKHTQNVALNIKLSAIKTKYLRELNVLEEKSKDELPSEIKAKLDAAFEKFKKDTLKPGEK (SEQ ID NO 2), or a functional variant or fragment thereof; or
ATENEGATQVPTSSNRANESQAEQGEQPKKLDSERDKARKEVEEYVKKIVGESYAKSTKKRHTITVALVNELNNIKNEYLNKIVESTSESQLQILMMESRSKVDEAVSKFEKDSSSSSSSDSSTKPEASDTAKPNKPTEPGEK (SEQ ID NO 9), or a functional variant or fragment thereof.
15 . The recombinant protein of claim 5 , wherein the protein comprises the sequence:
(SEQ ID NO 1)
ATENEGSTQAATSSNMAKTEHRKAAKQVVDEYIEKMLREIQLDRRK
HTQNVALNIKLSAIKTKYLRELNVLEEKSKDELPSEIKAKLDAAFE
KFKKDTLKPGEK,
or a functional variant or fragment thereof; or KQVVDEYIEKMLREIQLDRRKHTQNVALNIKLSAIKTKYLRELNVLEEKSKDELPSEIKAKLDAAFEKFKKDTLKPGEK (SEQ ID NO 2), or a functional variant or fragment thereof; or
ATENEGATQVPTSSNRANESQAEQGEQPKKLDSERDKARKEVEEYVKKIVGESYAKSTKKRHTITVALVNELNNIKNEYLNKIVESTSESQLQILMMESRSKVDEAVSKFEKDSSSSSSSDSSTKPEASDTAKPNKPTEPGEK (SEQ ID NO 9), or a functional variant or fragment thereof.
16 . The recombinant protein of claim 6 , wherein the protein comprises at least amino acids 68-136 of PspC, or a functional variant thereof.
17 . The recombinant protein of claim 1 , wherein the recombinant protein binds to CFH within complement control proteins (CCPs) 8-10 of CFH.
18 . The recombinant protein of claim 5 , wherein the recombinant protein binds to CFH within complement control proteins (CCPs) 8-10 of CFH.
19 . The recombinant protein of claim 9 , wherein the recombinant protein binds to CFH within complement control proteins (CCPs) 8-10 of CFH.Join the waitlist — get patent alerts
Track US2021017239A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.